User manual for Yinyanghuosu Ruanjiaonang, a conditionally approved soft capsule for unresectable hepatocellular carcinoma patients meeting specific…
This document is the user manual for Yinyanghuosu Ruanjiaonang, a soft capsule approved conditionally for treating unresectable hepatocellular carcinoma in patients who cannot or refuse standard treatment and have not received systemic therapy. It includes dosage, contraindications, adverse reactions, and monitoring requirements. The product must be used under physician supervision with validated biomarker testing required before administration.
The manual details clinical trial data, including efficacy results from Phase III trials comparing the drug to Huachansu tablets, with survival data for enriched populations showing a statistically significant improvement in overall survival for the Yinyanghuosu group. This manual is written in Chinese.
| 规格 | 每粒装 0.4g(含淫羊藿素 100mg) |
|---|---|
| 推荐剂量 | 一次 6粒,口服,一日 2次,于早、晚餐后 30分钟温水吞服 |
| 适应症 | 适用于不适合或患者拒绝接受标准治疗、且既往未接受过全身系统性治疗的不可切除肝细胞癌患者,外周血复合标志物满足至少两项指标 |
适用于不适合或患者拒绝接受标准治疗、且既往未接受过全身系统性治疗的不可切除肝细胞癌患者,外周血复合标志物满足至少两项指标:AFP≥400 ng/mL;TNF-α<2.5 pg/mL;IFN-γ≥7.0 pg/mL。
一次6粒,口服,一日2次,于早、晚餐后30分钟温水吞服。如果漏服一次且无法在餐后2小时内服用,则按计划下次服药,无需补服。
对本品及所含成分(淫羊藿素、玉米油、蜂蜡、明胶、甘油、二氧化钛和黄氧化铁)过敏者禁用。